Literature DB >> 34971360

Impacts of a high fat diet on the metabolic profile and the phenotype of atrial myocardium in mice.

Nadine Suffee1, Elodie Baptista1, Jérôme Piquereau2, Maharajah Ponnaiah3, Nicolas Doisne1, Farid Ichou3, Marie Lhomme3, Camille Pichard1, Vincent Galand1, Nathalie Mougenot4, Gilles Dilanian1, Laurence Lucats5, Elise Balse1, Mathias Mericskay2, Wilfried Le Goff1, Stéphane N Hatem6.   

Abstract

AIMS: Obesity, diabetes and metabolic syndromes are risk factors of atrial fibrillation (AF). We tested the hypothesis that metabolic disorders have a direct impact on the atria favoring the formation of the substrate of AF. METHODS &
RESULTS: Untargeted metabolomic and lipidomic analysis was used to investigate the consequences of a prolonged high fat diet (HFD) on mouse atria. Atrial properties were characterized by measuring mitochondria respiration in saponin-permeabilized trabeculae, by recording action potential with glass microelectrodes in trabeculae and ionic currents in myocytes using the perforated configuration of patch clamp technique and by several immuno-histological and biochemical approaches. After 16 weeks of HFD, obesogenic mice showed a vulnerability to AF. The atrial myocardium acquired an adipogenic and inflammatory phenotypes. Metabolomic and lipidomic analysis revealed a profound transformation of atrial energy metabolism with a predominance of long-chain lipid accumulation and beta-oxidation activation in the obese mice. Mitochondria respiration showed an increased use of palmitoyl-CoA as energy substrate. Action potentials were short duration and sensitive to the K-ATP-dependent channel inhibitor, whereas K-ATP current was enhanced in isolated atrial myocytes of obese mouse.
CONCLUSION: HFD transforms energy metabolism, causes fat accumulation, and induces electrical remodeling of the atrial myocardium of mice that become vulnerable to AF. TRANSLATIONAL PERSPECTIVE: Understanding the link between metabolic diseases and atrial fibrillation is of major importance. One hypothesis claims that, in addition to shared co-morbidities, metabolic disorders favor the substrate of atrial fibrillation. Here we show that after prolonged high fat diet, the atrial myocardium becomes adipogenic, inflamed and vulnerable to atrial fibrillation. This tissue remodeling appears to result from an unbalance between uptake and oxidation of fatty acid resulting in long-chain lipid storage, activation of metabolic-sensitive potassium channels and action potential shortening. Therefore, diet appears to be an important link between metabolic disorders and atrial fibrillation. Published on behalf of the European Society of Cardiology. All rights reserved.
© The Author(s) 2021. For permissions please email: journals.permissions@oup.com.

Entities:  

Year:  2021        PMID: 34971360     DOI: 10.1093/cvr/cvab367

Source DB:  PubMed          Journal:  Cardiovasc Res        ISSN: 0008-6363            Impact factor:   10.787


  3 in total

1.  MicroRNA-205-5p plays a suppressive role in the high-fat diet-induced atrial fibrosis through regulation of the EHMT2/IGFBP3 axis.

Authors:  Zezhou Xiao; Yu Xie; Fangze Huang; Jie Yang; Ximao Liu; Xuefeng Lin; Peng Zhu; Shaoyi Zheng
Journal:  Genes Nutr       Date:  2022-07-20       Impact factor: 4.423

2.  Combined metabolomic and transcriptomic profiling approaches reveal the cardiac response to high-fat diet.

Authors:  Leroy C Joseph; Jianting Shi; Quynh N Nguyen; Victoria Pensiero; Chris Goulbourne; Robert C Bauer; Hanrui Zhang; John P Morrow
Journal:  iScience       Date:  2022-04-01

3.  High liver fibrosis scores in metabolic dysfunction-associated fatty liver disease patients are associated with adverse atrial remodeling and atrial fibrillation recurrence following catheter ablation.

Authors:  Raphaël Decoin; Laura Butruille; Thomas Defrancq; Jordan Robert; Nicolas Destrait; Augustin Coisne; Samy Aghezzaf; Eloise Woitrain; Zouriatou Gouda; Sofia Schino; Cédric Klein; Patrice Maboudou; François Brigadeau; Didier Klug; Andre Vincentelli; David Dombrowicz; Bart Staels; David Montaigne; Sandro Ninni
Journal:  Front Endocrinol (Lausanne)       Date:  2022-08-31       Impact factor: 6.055

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.